Format

Send to:

Choose Destination
See comment in PubMed Commons below
HIV Med. 2001 Jul;2(3):166-73.

HIV-associated lipodystrophy.

Author information

  • 1National Centre in HIV Epidemiology and Clinical Research, Faculty of Medicine, University of New South Wales, Australia. pmallon@nchecr.unsw.edu.au

Abstract

The HIV associated lipodystrophy syndrome is characterized by fat loss from the periphery, fat accumulation in the abdominal, dorsocervical regions and breasts, and hyperlipidaemia, insulin resistance and lactic acidaemia. Although several mechanisms have been proposed to explain these abnormalities, the exact aetiology of the condition remains unclear and will likely prove to be complex. The principal clinical concerns that arise from this disorder are possible increased risks of premature atherosclerosis and cardiovascular disease. A variety of therapeutic interventions, designed to limit these risks, are under evaluation.

PMID:
11737397
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Blackwell Publishing
    Loading ...
    Write to the Help Desk